Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CITIGROUP INCC · Entity 2837 | Director | October 01, 2026 | October 03, 2026 |
| EMERSON ELECTRIC COEMR · Entity 2942 | Director | February 03, 2026 | February 05, 2026 |
| NORTHROP GRUMMAN CORP /DE/NOC · Entity 2963 | Director | May 20, 2026 | May 21, 2026 |
| PRECIGEN, INC.PGEN · Entity 4356 | Director | March 13, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CITIGROUP INC
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,818.2638 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 6.4904 · Balance 2,818.2638 F1: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 39,648.6968 |
Reported balance
After 2026-10-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 200.8455 · Balance 39,648.6968 F1: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors. F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Reinvestment of dividend equivalents under the Issuer's Compensation Plan for Non-Employee Directors.
F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors.
EMERSON ELECTRIC CO
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,458 |
Reported balance
After 2026-02-03 transaction · row 1
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 1,251 · Balance 27,458 F1: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2: Price is not applicable to acquisitions resulting from grants of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).
F2: Price is not applicable to acquisitions resulting from grants of restricted stock units.
NORTHROP GRUMMAN CORP /DE/
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,738 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 349 · Balance 6,738 F1: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2: Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3.
F2: Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
PRECIGEN, INC.
Report date March 13, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 685,417 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Exercise / conversion · Acquired 71,839 · Balance 685,417 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-13 · Exercise / conversion · Disposed 71,839 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2: The RSUs vested in full on March 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2: The RSUs vested in full on March 13, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2023 Filed Jul 5, 2023 20:08 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 63.3474 | $46.24 | $2,929.18 |
DisclosureSEC source: 0001209191-23-040981 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,343.8382 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:08 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 276.1752 | $46.24 | $12,770.34 |
DisclosureSEC source: 0001209191-23-040981 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 25,316.0543 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:46 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantCommon Stock | 392 | $447.34 | $175,357.28 |
DisclosureSEC source: 0001628280-23-019087 · wf-form4_168452916589288.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Amount includes (i) 635 shares of common stock; and (ii) 4,734 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 63.2762 | $45.78 | $2,896.91 |
DisclosureSEC source: 0001209191-23-022663 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,280.4908 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 2,531.4714 deferred shares of common stock transferred to the Reporting Person's deferred compensation account on 1/20/23 in accordance with the Reporting Person's prior election. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 275.865 | $45.78 | $12,629.65 |
DisclosureSEC source: 0001209191-23-022663 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 25,039.8791 F1 · shares: Reinvestment of cash, including dividends, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 2,531.4714 deferred shares of common stock transferred to the Reporting Person's deferred compensation account on 1/20/23 in accordance with the Reporting Person's prior election. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:08 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 125,489 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004011 · dp190530_4-turley.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,489 Underlying: Common Stock · 125,489 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:08 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004011 · dp190530_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837 Underlying: Common Stock · 106,837 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 9, 2024. F3 · derivative.expiration_date: The RSUs vest in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:08 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 53,418 | $1.17 | $62,499.06 |
DisclosureSEC source: 0000950103-23-004011 · dp190530_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,898 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 01:13 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 61,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-003033 · dp189564_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on February 22, 2023. F2 · derivative.expiration_date: The RSUs vested in full on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 01:13 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 61,576 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-003033 · dp189564_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 23:24 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-23-000043 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,864 F1 · kind: Grant to Reporting Person of 1,933 restricted stock units having a fair market value of $90.5250 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,933 restricted stock units having a fair market value of $90.5250 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock units. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 3,353.3041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000871 · doc4.xml · nonDerivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,748.686 F3 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 53.6724 | $45.82 | $2,459.27 |
DisclosureSEC source: 0001209191-23-000871 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,395.3819 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 245.6113 | $45.82 | $11,253.91 |
DisclosureSEC source: 0001209191-23-000871 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,232.5427 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 20:09 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 49.3999 | $49.18 | $2,429.24 |
DisclosureSEC source: 0001209191-22-052193 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,341.7095 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 20:09 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 226.0592 | $49.18 | $11,116.46 |
DisclosureSEC source: 0001209191-22-052193 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 21,986.9314 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 48.0012 | $50.04 | $2,401.93 |
DisclosureSEC source: 0001209191-22-041078 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,292.3096 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 219.6601 | $50.04 | $10,991.57 |
DisclosureSEC source: 0001209191-22-041078 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 21,760.8722 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| May 18, 2022 Filed May 19, 2022 21:41 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantCommon Stock | 385 | $454.87 | $175,124.95 |
DisclosureSEC source: 0001628280-22-014950 · wf-form4_165299645429244.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,916 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Amount includes (i) 635 shares of common stock; and (ii) 4,281 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:13 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 22.0598 | $56.20 | $1,239.76 |
DisclosureSEC source: 0001209191-22-022978 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,245.3084 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:13 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 193.7395 | $56.20 | $10,888.16 |
DisclosureSEC source: 0001209191-22-022978 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 21,541.2121 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 21:03 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-005402 · dp170037_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 25, 2022. F2 · derivative.expiration_date: The RSUs vested in full on March 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 21:03 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 16,212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-22-005402 · dp170037_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:51 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 83,189 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950103-22-003224 · dp167772_4-turley.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,189 Underlying: Common Stock · 83,189 shares Expires 2032-02-22 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:51 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 61,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-003224 · dp167772_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,576 Underlying: Common Stock · 61,576 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on February 22, 2023. F3 · derivative.expiration_date: The RSUs vest in full on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:51 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 30,788 | $2.03 | $62,499.64 |
DisclosureSEC source: 0000950103-22-003224 · dp167772_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,692 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:00 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 2,254.5542 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009383 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,223.2486 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Reflects 2,012.545 deferred shares of common stock transferred to the Reporting Person's deferred compensation account on 1/20/22 in accordance with the Reporting Person's prior election. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:05 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,905 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-22-000056 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,931 F1 · kind: Grant to Reporting Person of 1,905 shares of restricted stock having a fair market value of $91.83 per share on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,905 shares of restricted stock having a fair market value of $91.83 per share on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 21:26 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 36.2154 | $62.06 | $2,247.67 |
DisclosureSEC source: 0001209191-22-000769 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,981.2394 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 21:26 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 157.593 | $62.06 | $9,780.85 |
DisclosureSEC source: 0001209191-22-000769 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 19,334.9276 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 31.6701 | $70.46 | $2,231.54 |
DisclosureSEC source: 0001209191-21-058927 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,945.024 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 137.8137 | $70.46 | $9,710.63 |
DisclosureSEC source: 0001209191-21-058927 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 19,177.3346 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 28.2857 | $78.38 | $2,217.03 |
DisclosureSEC source: 0001209191-21-045417 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,913.3539 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:11 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 123.087 | $78.38 | $9,647.56 |
DisclosureSEC source: 0001209191-21-045417 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 19,039.5209 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| May 19, 2021 Filed May 21, 2021 17:58 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantCommon Stock | 458 | $370.90 | $169,872.20 |
DisclosureSEC source: 0001628280-21-010873 · wf-form4_162161991129671.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,467 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Amount includes (i) 635 shares of common stock; and (ii) 3,832 shares of common stock, including dividends, held in a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:12 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 13.9593 | $71.43 | $997.14 |
DisclosureSEC source: 0001209191-21-025125 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,885.0682 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:12 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 134.1104 | $71.43 | $9,579.77 |
DisclosureSEC source: 0001209191-21-025125 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,916.4339 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:50 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000569 · edgar.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:50 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000569 · edgar.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 23:50 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 8,106 | $7.71 | $62,497.26 |
DisclosureSEC source: 0001123292-21-000569 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,904 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000483 · edgar.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F2 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:31 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000483 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 22:53 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 2,378.0836 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010355 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,871.1089 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Reflects 2,546.2408 shares of deferred common stock which vested on 1/20/2021 and were transferred to the Reporting Person's deferred compensation account in accordance with the terms of the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 22:13 UTC | EMERSON ELECTRIC CO EMR · Entity 2942 | GrantCommon Stock | 1,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-21-000112 · edgar.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,026 F1 · kind: Grant to Reporting Person of 1,787 shares of restricted stock having a fair market value of $83.905 per share on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F1 · shares: Grant to Reporting Person of 1,787 shares of restricted stock having a fair market value of $83.905 per share on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d). F2 · price: Price is not applicable to acquisitions resulting from grants of restricted stock. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 39.1396 | $58.15 | $2,275.89 |
DisclosureSEC source: 0001209191-21-000993 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,039.2661 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 141.177 | $58.15 | $8,209.16 |
DisclosureSEC source: 0001209191-21-000993 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,236.0825 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 44.6604 | $50.45 | $2,253.21 |
DisclosureSEC source: 0001209191-20-053096 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000.1265 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:10 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 161.0901 | $50.45 | $8,127.32 |
DisclosureSEC source: 0001209191-20-053096 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,094.9055 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:13 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 40.9303 | $54.54 | $2,232.26 |
DisclosureSEC source: 0001209191-20-040266 · doc4.xml · nonDerivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,955.4661 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:13 UTC | CITIGROUP INC C · Entity 2837 | GrantCommon Stock | 147.6358 | $54.54 | $8,051.76 |
DisclosureSEC source: 0001209191-20-040266 · doc4.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,933.8154 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.